LEVOSIMENDAN EQL PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
LEVOSIMENDAN EQL PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Pending
Register Number
88752
Prescription Type
Uso Hospitalario
Authorization Date
Mar 31, 2023
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number88752
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
LEVOSIMENDANActive
Quantity: 2,5 mg/ml
Name: LEVOSIMENDAN
ATC CLASSIFICATION (3)
C01C
C01CX
C01CX08